{"id":16314,"date":"2011-12-05T13:03:00","date_gmt":"2011-12-05T13:03:00","guid":{"rendered":"https:\/\/www2.thestockmarketwatch.com\/stock-market-news\/a-couple-biotechnology-stocks-trading-on-the-nasdaq-affy-and-tear\/16307\/"},"modified":"2011-12-05T13:03:00","modified_gmt":"2011-12-05T13:03:00","slug":"a-couple-biotechnology-stocks-trading-on-the-nasdaq-affy-and-tear","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/a-couple-biotechnology-stocks-trading-on-the-nasdaq-affy-and-tear\/16314\/","title":{"rendered":"A Couple Biotechnology Stocks trading on the NASDAQ: AFFY and TEAR"},"content":{"rendered":"<p><script type=\"text\/javascript\"><!--\ngoogle_ad_client = \"ca-pub-1408583772585547\";\n\/* SMW - News Links *\/\ngoogle_ad_slot = \"3490797620\";\ngoogle_ad_width = 468;\ngoogle_ad_height = 15;\n\/\/-->\n<\/script><br \/>\n<script type=\"text\/javascript\" src=\"http:\/\/pagead2.googlesyndication.com\/pagead\/show_ads.js\">\n<\/script><\/p>\n<p><!--Ad Injection mfunc mode ad include code--><br \/>\n<!--mfunc include_once('\/mnt\/Target01\/327806\/www.thestockmarketwatch.com\/web\/content\/stock-market-news\/wp-content\/plugins\/ad-injection\/adshow.php') --><br \/>\n<!--\/mfunc--><\/p>\n<p>Affymax, Inc. (<a href=\"https:\/\/thestockmarketwatch.com\/stock.aspx?stock=affy\">NASDAQ:AFFY<\/a>) has traded as high as $6.59 during today\u2019s trading session and last traded at $6.35 for a gain of 20.95% from Friday\u2019s close! AFFY shares have traded as high as $8.50 over the past 52 weeks, which is over 25% off that high at last traded stock price. <a href=\"http:\/\/oi.vresp.com\/?fid=9df829089d\" target=\"_blank\" rel=\"noopener\"><strong>Get my next ALERT 100% FREE<\/strong><\/a><\/p>\n<p>Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax&#8217;s product candidate, peginesatide (formerly known as Hematide\u2122), has been investigated in Phase 3 clinical trials for the potential treatment of anemia associated with chronic renal failure.<\/p>\n<p>TearLab Corporation (<a href=\"https:\/\/thestockmarketwatch.com\/stock.aspx?stock=tear\">NASDAQ:TEAR<\/a>) has traded as high as $2.25 during today\u2019s trading session and last traded at $1.60 for a gain of 29% from Friday\u2019s close! TEAR shares have traded as high as $2.90 over the past 52 weeks, which is nearly 45% off that high at last traded stock price.<\/p>\n<p><!--mfunc adshow_display_ad_file_v2(array('ad_random_1.txt'), array(100), array('align' => 'float right', 'clear' => '', 'margin_top' => '', 'margin_bottom' => '', 'padding_top' => '', 'padding_bottom' => ''), array(), array()) --><\/p>\n<div style=\"float:right;margin-left:5px;\"><script type=\"text\/javascript\"><!--\ngoogle_ad_client = \"ca-pub-1408583772585547\";\n\/* SMW - in News 300 *\/\ngoogle_ad_slot = \"5684630733\";\ngoogle_ad_width = 300;\ngoogle_ad_height = 250;\n\/\/-->\n<\/script><br \/>\n<script type=\"text\/javascript\" src=\"http:\/\/pagead2.googlesyndication.com\/pagead\/show_ads.js\">\n<\/script><\/div>\n<p><!--\/mfunc--><\/p>\n<p>TEAR announced today the U.S. Food and Drug Administration has indicated through correspondence that, based on a supervisory review of the Company&#8217;s appeal, the Agency has granted its petition for a waiver under CLIA for the TearLab Osmolarity System. Upon the Company&#8217;s submission of labeling acceptable to the Agency, the CLIA waiver will be issued.<\/p>\n<p>&#8220;This marks the achievement of our third and final major milestone,&#8221; commented Elias Vamvakas, TearLab&#8217;s Chief Executive Officer. &#8220;We believe that in order for the TearLab Osmolarity System to become widely adopted, it is essential that it be accessible at the point-of-care. Now, with the CLIA waiver obstacle overcome, this groundbreaking test is free to start growing to its potential.&#8221;<\/p>\n<p>The TearLab Osmolarity System uses a novel lab-on-a-chip approach that requires less than 50 nL of tear fluid in order to measure tear Osmolarity. The TearLab Osmolarity System eliminates the challenges that previously prevented point-of-care Osmolarity testing. The TearLab System can produce a sample-to-answer result in less than 30 seconds.<\/p>\n<p>More Posts by this author<\/p>\n<ul>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/hot-stocks-to-watch\/three-nasdaq-stocks-having-a-pullback-ftwr-gale-and-tncc\/16398\"><br \/>\nThree NASDAQ Stocks having a Pullback: FTWR, GALE, and TNCC<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/hot-stocks-to-watch\/three-stocks-on-the-move-in-the-news-amr-pphm-and-ritt\/16394\"><br \/>\nThree Stocks on the Move in the News: AMR, PPHM, and RITT<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/hot-stocks-to-watch\/a-couple-biotechnology-stocks-trading-on-the-nasdaq-affy-and-tear\/16314\"><br \/>\nA Couple Biotechnology Stocks trading on the NASDAQ: AFFY and TEAR<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/hot-stocks-to-watch\/two-nasdaq-stocks-on-the-move-under-a-buck-ftwr-and-tncc\/16306\"><br \/>\nTwo NASDAQ Stocks on the Move under a Buck: FTWR and TNCC<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/hot-stocks-to-watch\/yrc-worldwide-surges-with-1300-reverse-split\/16195\"><br \/>\nYRC Worldwide surges with 1:300 Reverse Split<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/hot-stocks-to-watch\/three-cheap-amex-stocks-in-play-aen-api-and-cfw\/16192\"><br \/>\nThree Cheap AMEX Stocks in Play: AEN, API, and CFW<\/a><\/li>\n<li><a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/hot-stocks-to-watch\/three-stock-under-5-on-the-move-nm-rby-and-mitl\/16184\"><br \/>\nThree Stock under $5 on the Move: NM, RBY, and MITL<\/a><\/li>\n<\/ul>\n<hr>\n<table style=\"border:none;margin:0;\">\n<tr>\n<td style=\"padding:5px;vertical-align:top;\" valign=\"top\">\n <\/td>\n<td style=\"padding:5px;vertical-align:top;\" valign=\"top\">\n<div style=\"font-size:11pt;\"><b>Post Written By: Oliver Crowne <\/b><\/div>\n<div style=\"font-size:10pt;\">\n<p>Oliver Crowne is the main editor for <a href=\"http:\/\/www.stockpreacher.com\/\" target=\"_blank\" rel=\"noopener\">http:\/\/www.StockPreacher.com<\/a>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<p><script type=\"text\/javascript\"><!--\ngoogle_ad_client = \"pub-1408583772585547\";\n\/* 336x280, created 7\/9\/11 *\/\ngoogle_ad_slot = \"3552319058\";\ngoogle_ad_width = 336;\ngoogle_ad_height = 280;\n\/\/-->\n<\/script><br \/>\n<script type=\"text\/javascript\" src=\"http:\/\/pagead2.googlesyndication.com\/pagead\/show_ads.js\">\n<\/script><\/p>\n<div style=\"margin:5px;margin-bottom:20px;font-size:11pt;\">&laquo; <a href=\"https:\/\/thestockmarketwatch.com\/stock-market-news\/\">Return to Stock Market News<\/a> &laquo; <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Affymax, Inc. (NASDAQ:AFFY) has traded as high as $6.59 during today\u2019s trading session and last traded at $6.35 for a [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50312,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[6],"tags":[],"class_list":["post-16314","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hot-stocks-to-watch"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/16314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=16314"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/16314\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50312"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=16314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=16314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=16314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}